Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
3.218
+0.098 (3.15%)
Oct 15, 2026, 11:23 AM EDT - Market open
Medicus Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 15.17 | 8.71 | 4.16 | 1.72 | 0.27 | 0.08 |
Cash & Short-Term Investments | 15.17 | 8.71 | 4.16 | 1.72 | 0.27 | 0.08 |
Cash Growth | 56.93% | 109.04% | 142.21% | 542.38% | 240.90% | - |
Prepaid Expenses | 1.42 | 0.68 | 0.76 | 0.17 | 0.02 | - |
Other Current Assets | 0.39 | 0.51 | 0.46 | - | - | - |
Total Current Assets | 16.98 | 9.89 | 5.38 | 1.89 | 0.28 | 0.08 |
Property, Plant & Equipment | 0.12 | 0.17 | 0.27 | - | - | - |
Total Assets | 27.12 | 10.06 | 5.65 | 1.89 | 0.28 | 0.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.73 | 3.44 | 1.28 | 0.21 | 0.1 | 0.16 |
Accrued Expenses | 0.47 | 1.11 | 0.91 | 0.4 | - | - |
Short-Term Debt | 3.5 | 5.25 | - | 0.17 | 1.53 | 0.67 |
Current Portion of Leases | 0.14 | 0.15 | 0.12 | - | - | - |
Other Current Liabilities | - | - | - | - | 10.85 | 9.75 |
Total Current Liabilities | 10.84 | 9.94 | 2.31 | 0.78 | 12.48 | 10.58 |
Long-Term Debt | 18 | 0.03 | - | - | - | - |
Long-Term Leases | - | 0.06 | 0.21 | - | - | - |
Total Liabilities | 28.84 | 10.02 | 2.51 | 0.78 | 12.48 | 10.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 74.3 | 57.08 | 30.52 | 18.76 | 0.19 | 0.19 |
Additional Paid-In Capital | 8.88 | 6.88 | 1.52 | 0.1 | - | - |
Retained Earnings | -85.01 | -64.35 | -28.9 | -17.75 | -12.39 | -10.7 |
Comprehensive Income & Other | 0.06 | 0.32 | - | - | - | - |
Total Common Equity | -1.76 | -0.07 | 3.13 | 1.11 | -12.2 | -10.51 |
Minority Interest | 0.04 | 0.1 | - | - | - | - |
Shareholders' Equity | -1.72 | 0.04 | 3.13 | 1.11 | -12.2 | -10.51 |
Total Liabilities & Equity | 27.12 | 10.06 | 5.65 | 1.89 | 0.28 | 0.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 21.64 | 5.48 | 0.32 | 0.17 | 1.53 | 0.67 |
Net Cash (Debt) | -6.46 | 3.23 | 3.84 | 1.55 | -1.26 | -0.59 |
Net Cash Growth | - | -15.98% | 147.33% | - | - | - |
Net Cash Per Share | -9.47 | 9.34 | 19.97 | 22.32 | -33.53 | -9.16 |
Filing Date Shares Outstanding | 1.26 | 0.79 | 0.24 | 0.16 | 6.43 | 0.06 |
Total Common Shares Outstanding | 1.2 | 0.5 | 0.24 | 0.16 | 6.43 | 0.06 |
Working Capital | 6.14 | -0.05 | 3.07 | 1.11 | -12.2 | -10.51 |
Book Value Per Share | -1.47 | -0.13 | 13.26 | 6.88 | -1.90 | -163.28 |
Tangible Book Value | -1.76 | -0.07 | 3.13 | 1.11 | -12.2 | -10.51 |
Tangible Book Value Per Share | -1.47 | -0.13 | 13.26 | 6.88 | -1.90 | -163.28 |